ArticleBMC cancer2026

Clinical profiling of AML1::ETO and KIT exon 17 mutation in pediatric AML by high-throughput drug sensitivity.

Zhilin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.